Neurocrine biosciences reports fourth quarter and full-year 2020 financial results

San diego, feb. 4, 2021 /prnewswire/ -- neurocrine biosciences, inc. (nasdaq: nbix) today announced its financial results for the fourth quarter and full-year ended december 31, 2020 and provided full-year 2021 financial expense guidance. "in 2020, we served more patients with tardive...

NBIX Ratings Summary

NBIX Quant Ranking